盖茨基金会新战略：5200万美元投资德国疫苗公司CureVac

2015-03-11 佚名不详

近日，比尔与梅琳达·盖茨基金会斥5200万美元投资了一家德国的疫苗生产商CureVac。这是盖茨基金会有史以来对公司的最大投资。CureVac此轮融资共获得了7600万美元，公司计划使用mRNA作为模板开发新的药物和疫苗。这项举措也反应了基金会的最新战略，不仅要做捐款，也要支持商业并拥有公司股份。 CureVac此轮融资共获得了7600万美元，公司计划以mRNA作为模板开发新的药物和疫苗。C

近日，比尔与梅琳达·盖茨基金会斥5200万美元投资了一家德国的疫苗生产商CureVac。这是盖茨基金会有史以来对公司的最大投资。CureVac此轮融资共获得了7600万美元，公司计划使用mRNA作为模板开发新的药物和疫苗。这项举措也反应了基金会的最新战略，不仅要做捐款，也要支持商业并拥有公司股份。

CureVac此轮融资共获得了7600万美元，公司计划以mRNA作为模板开发新的药物和疫苗。CureVac拥有最广泛和最先进的mRNA治疗平台。通过该平台可以快速、低成本的生存多种药物和疫苗。此外，CureVac的mRNA疫苗具有耐热性，这就消除了冷藏设备的需求。这是很多发展中国家供应疫苗面临的重大挑战。

比尔？盖茨在一份声明中表示：“如果我们能够教会身体创建自己的自然防御系统，这将彻底改变我们对疾病的预防和治疗。类似mRNA这样的技术给了我们下赌注的信心。我们很高兴CureVac率先拥有了这一技术。”

去年的86亿投资中，获得最高投资（4.46亿）的生物科技公司Moderna Therapeutics也是从事mRNA的新药研发的。看来，这确实是值得关注的一个领域啊。（生物谷Bioon.com）

信源：福布斯

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (6)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=62625, encodeId=b53c6262578, content=看人家, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Mon Feb 01 22:35:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62626, encodeId=384762626c3, content=慈善事业好, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Mon Feb 01 22:35:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988934, encodeId=1e46198893445, content=<a href='/topic/show?id=32fae23737b' target=_blank style='color:#2F92EE;'>#盖茨基金会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72373, encryptionId=32fae23737b, topicName=盖茨基金会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Tue Feb 23 22:11:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783917, encodeId=8a9e1e83917e3, content=<a href='/topic/show?id=eefa550380' target=_blank style='color:#2F92EE;'>#Cure#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5503, encryptionId=eefa550380, topicName=Cure)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Thu Mar 26 22:11:00 CST 2015, time=2015-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394296, encodeId=7b09139429692, content=<a href='/topic/show?id=6fa7508342c' target=_blank style='color:#2F92EE;'>#德国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50834, encryptionId=6fa7508342c, topicName=德国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Mar 13 00:11:00 CST 2015, time=2015-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493256, encodeId=db84149325603, content=<a href='/topic/show?id=03d05504ba' target=_blank style='color:#2F92EE;'>#CureVac#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5504, encryptionId=03d05504ba, topicName=CureVac)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31089012323, createdName=doctor-chen9585, createdTime=Fri Mar 13 00:11:00 CST 2015, time=2015-03-13, status=1, ipAttribution=)]
2016-02-01 收获你的美

看人家

152 0
[GetPortalCommentsPageByObjectIdResponse(id=62625, encodeId=b53c6262578, content=看人家, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Mon Feb 01 22:35:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62626, encodeId=384762626c3, content=慈善事业好, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Mon Feb 01 22:35:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988934, encodeId=1e46198893445, content=<a href='/topic/show?id=32fae23737b' target=_blank style='color:#2F92EE;'>#盖茨基金会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72373, encryptionId=32fae23737b, topicName=盖茨基金会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Tue Feb 23 22:11:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783917, encodeId=8a9e1e83917e3, content=<a href='/topic/show?id=eefa550380' target=_blank style='color:#2F92EE;'>#Cure#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5503, encryptionId=eefa550380, topicName=Cure)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Thu Mar 26 22:11:00 CST 2015, time=2015-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394296, encodeId=7b09139429692, content=<a href='/topic/show?id=6fa7508342c' target=_blank style='color:#2F92EE;'>#德国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50834, encryptionId=6fa7508342c, topicName=德国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Mar 13 00:11:00 CST 2015, time=2015-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493256, encodeId=db84149325603, content=<a href='/topic/show?id=03d05504ba' target=_blank style='color:#2F92EE;'>#CureVac#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5504, encryptionId=03d05504ba, topicName=CureVac)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31089012323, createdName=doctor-chen9585, createdTime=Fri Mar 13 00:11:00 CST 2015, time=2015-03-13, status=1, ipAttribution=)]
2016-02-01 收获你的美

慈善事业好

169 0
[GetPortalCommentsPageByObjectIdResponse(id=62625, encodeId=b53c6262578, content=看人家, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Mon Feb 01 22:35:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62626, encodeId=384762626c3, content=慈善事业好, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Mon Feb 01 22:35:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988934, encodeId=1e46198893445, content=<a href='/topic/show?id=32fae23737b' target=_blank style='color:#2F92EE;'>#盖茨基金会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72373, encryptionId=32fae23737b, topicName=盖茨基金会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Tue Feb 23 22:11:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783917, encodeId=8a9e1e83917e3, content=<a href='/topic/show?id=eefa550380' target=_blank style='color:#2F92EE;'>#Cure#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5503, encryptionId=eefa550380, topicName=Cure)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Thu Mar 26 22:11:00 CST 2015, time=2015-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394296, encodeId=7b09139429692, content=<a href='/topic/show?id=6fa7508342c' target=_blank style='color:#2F92EE;'>#德国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50834, encryptionId=6fa7508342c, topicName=德国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Mar 13 00:11:00 CST 2015, time=2015-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493256, encodeId=db84149325603, content=<a href='/topic/show?id=03d05504ba' target=_blank style='color:#2F92EE;'>#CureVac#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5504, encryptionId=03d05504ba, topicName=CureVac)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31089012323, createdName=doctor-chen9585, createdTime=Fri Mar 13 00:11:00 CST 2015, time=2015-03-13, status=1, ipAttribution=)]
2016-02-23 chendoc242

#盖茨基金会#

64 0
[GetPortalCommentsPageByObjectIdResponse(id=62625, encodeId=b53c6262578, content=看人家, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Mon Feb 01 22:35:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62626, encodeId=384762626c3, content=慈善事业好, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Mon Feb 01 22:35:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988934, encodeId=1e46198893445, content=<a href='/topic/show?id=32fae23737b' target=_blank style='color:#2F92EE;'>#盖茨基金会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72373, encryptionId=32fae23737b, topicName=盖茨基金会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Tue Feb 23 22:11:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783917, encodeId=8a9e1e83917e3, content=<a href='/topic/show?id=eefa550380' target=_blank style='color:#2F92EE;'>#Cure#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5503, encryptionId=eefa550380, topicName=Cure)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Thu Mar 26 22:11:00 CST 2015, time=2015-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394296, encodeId=7b09139429692, content=<a href='/topic/show?id=6fa7508342c' target=_blank style='color:#2F92EE;'>#德国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50834, encryptionId=6fa7508342c, topicName=德国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Mar 13 00:11:00 CST 2015, time=2015-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493256, encodeId=db84149325603, content=<a href='/topic/show?id=03d05504ba' target=_blank style='color:#2F92EE;'>#CureVac#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5504, encryptionId=03d05504ba, topicName=CureVac)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31089012323, createdName=doctor-chen9585, createdTime=Fri Mar 13 00:11:00 CST 2015, time=2015-03-13, status=1, ipAttribution=)]
2015-03-26 徐岩

#Cure#

72 0
[GetPortalCommentsPageByObjectIdResponse(id=62625, encodeId=b53c6262578, content=看人家, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Mon Feb 01 22:35:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62626, encodeId=384762626c3, content=慈善事业好, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Mon Feb 01 22:35:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988934, encodeId=1e46198893445, content=<a href='/topic/show?id=32fae23737b' target=_blank style='color:#2F92EE;'>#盖茨基金会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72373, encryptionId=32fae23737b, topicName=盖茨基金会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Tue Feb 23 22:11:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783917, encodeId=8a9e1e83917e3, content=<a href='/topic/show?id=eefa550380' target=_blank style='color:#2F92EE;'>#Cure#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5503, encryptionId=eefa550380, topicName=Cure)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Thu Mar 26 22:11:00 CST 2015, time=2015-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394296, encodeId=7b09139429692, content=<a href='/topic/show?id=6fa7508342c' target=_blank style='color:#2F92EE;'>#德国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50834, encryptionId=6fa7508342c, topicName=德国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Mar 13 00:11:00 CST 2015, time=2015-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493256, encodeId=db84149325603, content=<a href='/topic/show?id=03d05504ba' target=_blank style='color:#2F92EE;'>#CureVac#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5504, encryptionId=03d05504ba, topicName=CureVac)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31089012323, createdName=doctor-chen9585, createdTime=Fri Mar 13 00:11:00 CST 2015, time=2015-03-13, status=1, ipAttribution=)]
2015-03-13 12498c32m68暂无昵称

#德国#

78 0
[GetPortalCommentsPageByObjectIdResponse(id=62625, encodeId=b53c6262578, content=看人家, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Mon Feb 01 22:35:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=62626, encodeId=384762626c3, content=慈善事业好, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwlM29ic8TDJMJOiarryMIZZhTjXxyRT9lffSWpWWcWojnL7ibJwcOn99ayict8FJ9ICYmNh9swD6R4E/0, createdBy=196f1683049, createdName=收获你的美, createdTime=Mon Feb 01 22:35:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988934, encodeId=1e46198893445, content=<a href='/topic/show?id=32fae23737b' target=_blank style='color:#2F92EE;'>#盖茨基金会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72373, encryptionId=32fae23737b, topicName=盖茨基金会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Tue Feb 23 22:11:00 CST 2016, time=2016-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783917, encodeId=8a9e1e83917e3, content=<a href='/topic/show?id=eefa550380' target=_blank style='color:#2F92EE;'>#Cure#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5503, encryptionId=eefa550380, topicName=Cure)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Thu Mar 26 22:11:00 CST 2015, time=2015-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394296, encodeId=7b09139429692, content=<a href='/topic/show?id=6fa7508342c' target=_blank style='color:#2F92EE;'>#德国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50834, encryptionId=6fa7508342c, topicName=德国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Mar 13 00:11:00 CST 2015, time=2015-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493256, encodeId=db84149325603, content=<a href='/topic/show?id=03d05504ba' target=_blank style='color:#2F92EE;'>#CureVac#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5504, encryptionId=03d05504ba, topicName=CureVac)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31089012323, createdName=doctor-chen9585, createdTime=Fri Mar 13 00:11:00 CST 2015, time=2015-03-13, status=1, ipAttribution=)]
2015-03-13 doctor-chen9585

#CureVac#

75 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

热点

盖茨基金会新战略：5200万美元投资德国疫苗公司CureVac

相关资讯

科室

工具

服务